Evidence map›Paper›PMID 20955582›Full record

Trial reportBMC public health2010

Effectiveness and cost-effectiveness of early assisted discharge for chronic obstructive pulmonary disease exacerbations: the design of a randomised controlled trial.

Cecile M A Utens, Lucas M A Goossens, Frank W J M Smeenk, Onno C P van Schayck, Walter van Litsenburg, Annet Janssen, Monique van Vliet, Wiel Seezink, Dirk R A J Demunck, Brigitte van de Pas and 8 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMC public health, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Early discharge hospital at home.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Asthma monitoring in primary care: time to gather more robust evidence.Primary care respiratory journal : journal of the General Practice Airways Group · 2012
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Cecile M A UtensDepartment of Respiratory Medicine, Catharina Hospital Eindhoven, Eindhoven, the Netherlands. cecile.utens@cze.nl
Lucas M A Goossens
Frank W J M Smeenk
Onno C P van Schayck
Walter van Litsenburg
Annet Janssen
Monique van Vliet
Wiel Seezink
Dirk R A J Demunck
Brigitte van de Pas
Peter J de Bruijn
Anouschka van der Pouw
Jeroen M A M Retera
Petra de Laat-Bierings
Loes van Eijsden
Maria Braken
Riet Eijsermans
Maureen P M H Rutten-van Mölken

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExacerbations of chronic obstructive pulmonary disease (COPD) are the main cause for hospitalisation. These hospitalisations result in a high pressure on hospital beds and high health care costs. Because of the increasing prevalence of COPD this will only become worse. Hospital at home is one of the alternatives that has been proved to be a safe alternative for hospitalisation in COPD. Most schemes are early assisted discharge schemes with specialised respiratory nurses providing care at home. Whether this type of service is cost-effective depends on the setting in which it is delivered and the way in which it is organised. METHODS/

designGO AHEAD (Assessment Of Going Home under Early Assisted Discharge) is a 3-months, randomised controlled, multi-centre clinical trial. Patients admitted to hospital for a COPD exacerbation are either discharged on the fourth day of admission and further treated at home, or receive usual inpatient hospital care. Home treatment is supervised by general nurses. Primary outcome is the effectiveness and cost effectiveness of an early assisted discharge intervention in comparison with usual inpatient hospital care for patients hospitalised with a COPD exacerbation. Secondary outcomes include effects on quality of life, primary informal caregiver burden and patient and primary caregiver satisfaction. Additionally, a discrete choice experiment is performed to provide insight in patient and informal caregiver preferences for different treatment characteristics. Measurements are performed on the first day of admission and 3 days, 7 days, 1 month and 3 months thereafter. Ethical approval has been obtained and the study has been registered. DISCUSSION: This article describes the study protocol of the GO AHEAD study. Early assisted discharge could be an effective and cost-effective method to reduce length of hospital stay in the Netherlands which is beneficial for patients and society. If effectiveness and cost-effectiveness can be proven, implementation in the Dutch health care system should be considered.

trial registrationNetherlands Trial Register NTR1129.

Indexed as

AdultCost-Benefit AnalysisFemaleHome Care ServicesHumansLength of StayMaleNetherlandsPatient DischargeProgram EvaluationPulmonary Disease, Chronic ObstructiveResearch DesignSample SizeSurveys and Questionnaires

Identifiers

PMID20955582
PMCPMC2965725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.